Chronic lymphocytic leukaemia
The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Hallek, M., Cheson, B. D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M. J., Montserrat, E., Rai, K. R., et al. (2008) · Blood · doi:10.1182/blood-2007-06-093906 · Cited by 3,787
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
Döhner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Kröber, A., Bullinger, L., Döhner, K., Bentz, M., & Lichter, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432602 · Cited by 3,318
WHO Classification: Tumours of the Haematopoietic and Lymphoid Tissues (2008)
(2015) · Postgraduate Haematology · doi:10.1002/9781118853771.ch51 · Cited by 3,290
Clinical staging of chronic lymphocytic leukemia
Rai, K., Sawitsky, A., Cronkite, E., Chanana, A., Levy, R., & Pasternack, B. (1975) · Blood · doi:10.1182/blood.v46.2.219.219 · Cited by 2,784
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G., & Stevenson, F. K. (1999) · Blood · doi:10.1182/blood.v94.6.1848 · Cited by 2,783
Damle, R. N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S. L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., et al. (1999) · Blood · doi:10.1182/blood.v94.6.1840 · Cited by 2,642
Hallek, M., Fischer, K., Fingerle-Rowson, G., Fink, A., Busch, R., Mayer, J., Hensel, M., Hopfinger, G., Hess, G., von Grünhagen, U., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61381-5 · Cited by 1,888
Cheson, B., Bennett, J., Grever, M., Kay, N., Keating, M., O'Brien, S., & Rai, K. (1996) · Blood · doi:10.1182/blood.v87.12.4990.bloodjournal87124990 · Cited by 1,819
Binet, J. L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., et al. (1981) · Cancer · doi:10.1002/1097-0142(19810701)48:1<198::aid-cncr2820480131>3.0.co;2-v · Cited by 1,778
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
Furman, R. R., Sharman, J. P., Coutre, S. E., Cheson, B. D., Pagel, J. M., Hillmen, P., Barrientos, J. C., Zelenetz, A. D., Kipps, T. J., Flinn, I., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315226 · Cited by 1,710
Self-citationIbrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
Byrd, J. C., Brown, J. R., O'Brien, S., Barrientos, J. C., Kay, N. E., Reddy, N. M., Coutre, S., Tam, C. S., Mulligan, S. P., Jaeger, U., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400376 · Cited by 1,639
Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
Goede, V., Fischer, K., Busch, R., Engelke, A., Eichhorst, B., Wendtner, C. M., Chagorova, T., de la Serna, J., Dilhuydy, M.-S., Illmer, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313984 · Cited by 1,518
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Puente, X. S., Pinyol, M., Quesada, V., Conde, L., Ordóñez, G. R., Villamor, N., Escaramis, G., Jares, P., Beà, S., González-Díaz, M., et al. (2011) · Nature · doi:10.1038/nature10113 · Cited by 1,514
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Wang, L., Lawrence, M. S., Wan, Y., Stojanov, P., Sougnez, C., Stevenson, K., Werner, L., Sivachenko, A., DeLuca, D. S., Zhang, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109016 · Cited by 1,080
Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., Marcé, S., López-Guillermo, A., Campo, E., & Montserrat, E. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023143 · Cited by 1,055
Quesada, V., Conde, L., Villamor, N., Ordóñez, G. R., Jares, P., Bassaganyas, L., Ramsay, A. J., Beà, S., Pinyol, M., Martínez-Trillos, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.1032 · Cited by 996
Keating, M. J., O’Brien, S., Albitar, M., Lerner, S., Plunkett, W., Giles, F., Andreeff, M., Cortes, J., Faderl, S., Thomas, D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.051 · Cited by 950
Fais, F., Ghiotto, F., Hashimoto, S., Sellars, B., Valetto, A., Allen, S. L., Schulman, P., Vinciguerra, V. P., Rai, K., Rassenti, L. Z., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3009 · Cited by 872
Rassenti, L. Z., Huynh, L., Toy, T. L., Chen, L., Keating, M. J., Gribben, J. G., Neuberg, D. S., Flinn, I. W., Rai, K. R., Byrd, J. C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040857 · Cited by 745
Tam, C. S., O'Brien, S., Wierda, W., Kantarjian, H., Wen, S., Do, K.-A., Thomas, D. A., Cortes, J., Lerner, S., & Keating, M. J. (2008) · Blood · doi:10.1182/blood-2008-02-140582 · Cited by 693
TP53 Mutation and Survival in Chronic Lymphocytic Leukemia
Zenz, T., Eichhorst, B., Busch, R., Denzel, T., Häbe, S., Winkler, D., Bühler, A., Edelmann, J., Bergmann, M., Hopfinger, G., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.8762 · Cited by 617
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
Fabbri, G., Rasi, S., Rossi, D., Trifonov, V., Khiabanian, H., Ma, J., Grunn, A., Fangazio, M., Capello, D., Monti, S., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110921 · Cited by 610
Brown, J. R., Byrd, J. C., Coutre, S. E., Benson, D. M., Flinn, I. W., Wagner-Johnston, N. D., Spurgeon, S. E., Kahl, B. S., Bello, C., Webb, H. K., et al. (2014) · Blood · doi:10.1182/blood-2013-11-535047 · Cited by 590
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
Wierda, W. G., Kipps, T. J., Mayer, J., Stilgenbauer, S., Williams, C. D., Hellmann, A., Robak, T., Furman, R. R., Hillmen, P., Trneny, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.3187 · Cited by 590
Stamatopoulos, K., Belessi, C., Moreno, C., Boudjograh, M., Guida, G., Smilevska, T., Belhoul, L., Stella, S., Stavroyianni, N., Crespo, M., et al. (2007) · Blood · doi:10.1182/blood-2006-03-012948 · Cited by 534
Self-citationGene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial
Stilgenbauer, S., Schnaiter, A., Paschka, P., Zenz, T., Rossi, M., Döhner, K., Bühler, A., Böttcher, S., Ritgen, M., Kneba, M., et al. (2014) · Blood · doi:10.1182/blood-2014-01-546150 · Cited by 516
O'Brien, S., Furman, R. R., Coutre, S. E., Sharman, J. P., Burger, J. A., Blum, K. A., Grant, B., Richards, D. A., Coleman, M., Wierda, W. G., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70513-8 · Cited by 466
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
Rossi, D., Rasi, S., Fabbri, G., Spina, V., Fangazio, M., Forconi, F., Marasca, R., Laurenti, L., Bruscaggin, A., Cerri, M., et al. (2012) · Blood · doi:10.1182/blood-2011-09-379966 · Cited by 462
Böttcher, S., Ritgen, M., Fischer, K., Stilgenbauer, S., Busch, R. M., Fingerle-Rowson, G., Fink, A. M., Bühler, A., Zenz, T., Wenger, M. K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.9348 · Cited by 460
Knauf, W. U., Lissichkov, T., Aldaoud, A., Liberati, A. M., Loscertales, J., Herbrecht, R., Juliusson, G., Postner, G., Gercheva, L., Goranova-Marinova, V. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8389 · Cited by 444
Fischer, K., Cramer, P., Busch, R., Böttcher, S., Bahlo, J., Schubert, J., Pflüger, K. H., Schott, S., Goede, V., Isfort, S., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.2688 · Cited by 433
Agathangelidis, A., Darzentas, N., Hadzidimitriou, A., Brochet, X., Murray, F., Yan, X.-J., Davis, Z., van Gastel-Mol, E. J., Tresoldi, C., Chu, C. C., et al. (2012) · Blood · doi:10.1182/blood-2011-11-393694 · Cited by 393
Self-citationZenz, T., Kröber, A., Scherer, K., Häbe, S., Bühler, A., Benner, A., Denzel, T., Winkler, D., Edelmann, J., Schwänen, C., et al. (2008) · Blood · doi:10.1182/blood-2008-04-154070 · Cited by 386
Rossi, D., Bruscaggin, A., Spina, V., Rasi, S., Khiabanian, H., Messina, M., Fangazio, M., Vaisitti, T., Monti, S., Chiaretti, S., et al. (2011) · Blood · doi:10.1182/blood-2011-08-373159 · Cited by 369
A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia
Di Bernardo, M. C., Crowther-Swanepoel, D., Broderick, P., Webb, E., Sellick, G., Wild, R., Sullivan, K., Vijayakrishnan, J., Wang, Y., Pittman, A. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.219 · Cited by 357
Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
Stankovic, T., Weber, P., Stewart, G., Bedenham, T., Murray, J., Byrd, P. J., Moss, P. A., & Taylor, A. M. R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10117-4 · Cited by 356
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
Rossi, D., Khiabanian, H., Spina, V., Ciardullo, C., Bruscaggin, A., Famà, R., Rasi, S., Monti, S., Deambrogi, C., De Paoli, L., et al. (2014) · Blood · doi:10.1182/blood-2013-11-539726 · Cited by 338
Eichhorst, B. F., Busch, R., Stilgenbauer, S., Stauch, M., Bergmann, M. A., Ritgen, M., Kranzhöfer, N., Rohrberg, R., Söling, U., Burkhard, O., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206185 · Cited by 333
Schuh, A., Becq, J., Humphray, S., Alexa, A., Burns, A., Clifford, R., Feller, S. M., Grocock, R., Henderson, S., Khrebtukova, I., et al. (2012) · Blood · doi:10.1182/blood-2012-05-433540 · Cited by 322
Rossi, D., Fangazio, M., Rasi, S., Vaisitti, T., Monti, S., Cresta, S., Chiaretti, S., Del Giudice, I., Fabbri, G., Bruscaggin, A., et al. (2012) · Blood · doi:10.1182/blood-2011-12-395673 · Cited by 289
Recurrent mutations refine prognosis in chronic lymphocytic leukemia
Baliakas, P., Hadzidimitriou, A., Sutton, L.-A., Rossi, D., Minga, E., Villamor, N., Larrayoz, M., Kminkova, J., Agathangelidis, A., Davis, Z., et al. (2015) · Leukemia · doi:10.1038/leu.2014.196 · Cited by 287
Self-citationZenz, T., Häbe, S., Denzel, T., Mohr, J., Winkler, D., Bühler, A., Sarno, A., Groner, S., Mertens, D., Busch, R., et al. (2009) · Blood · doi:10.1182/blood-2009-05-224071 · Cited by 285
Ghia, P., Guida, G., Stella, S., Gottardi, D., Geuna, M., Strola, G., Scielzo, C., & Caligaris-Cappio, F. (2003) · Blood · doi:10.1182/blood-2002-06-1801 · Cited by 260
Self-citationMarcucci, F., & Mele, A. (2011) · Blood · doi:10.1182/blood-2010-06-275818 · Cited by 253
Gattei, V., Bulian, P., Del Principe, M. I., Zucchetto, A., Maurillo, L., Buccisano, F., Bomben, R., Dal-Bo, M., Luciano, F., Rossi, F. M., et al. (2008) · Blood · doi:10.1182/blood-2007-05-092486 · Cited by 248
Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management
Shanafelt, T. D., Ghia, P., Lanasa, M. C., Landgren, O., & Rawstron, A. C. (2010) · Leukemia · doi:10.1038/leu.2009.287 · Cited by 227
Self-citationCommon variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk
Crowther-Swanepoel, D., Broderick, P., Di Bernardo, M. C., Dobbins, S. E., Torres, M., Mansouri, M., Ruiz-Ponte, C., Enjuanes, A., Rosenquist, R., Carracedo, A., et al. (2010) · Nature Genetics · doi:10.1038/ng.510 · Cited by 225
CD38 and chronic lymphocytic leukemia: a decade later
Malavasi, F., Deaglio, S., Damle, R., Cutrona, G., Ferrarini, M., & Chiorazzi, N. (2011) · Blood · doi:10.1182/blood-2011-06-275610 · Cited by 224
Flinn, I. W., Kahl, B. S., Leonard, J. P., Furman, R. R., Brown, J. R., Byrd, J. C., Wagner-Johnston, N. D., Coutre, S. E., Benson, D. M., Peterman, S., et al. (2014) · Blood · doi:10.1182/blood-2013-11-538546 · Cited by 210
Elter, T., Borchmann, P., Schulz, H., Reiser, M., Trelle, S., Schnell, R., Jensen, M., Staib, P., Schinköthe, T., Stützer, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.9950 · Cited by 209
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
Berndt, S. I., Skibola, C. F., Joseph, V., Camp, N. J., Nieters, A., Wang, Z., Cozen, W., Monnereau, A., Wang, S. S., Kelly, R. S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2652 · Cited by 205
Dreger, P., Schetelig, J., Andersen, N., Corradini, P., van Gelder, M., Gribben, J., Kimby, E., Michallet, M., Moreno, C., Stilgenbauer, S., et al. (2014) · Blood · doi:10.1182/blood-2014-07-586826 · Cited by 199
NOTCH1 mutations in CLL associated with trisomy 12
Balatti, V., Bottoni, A., Palamarchuk, A., Alder, H., Rassenti, L. Z., Kipps, T. J., Pekarsky, Y., & Croce, C. M. (2012) · Blood · doi:10.1182/blood-2011-10-386144 · Cited by 199
Del Giudice, I., Rossi, D., Chiaretti, S., Marinelli, M., Tavolaro, S., Gabrielli, S., Laurenti, L., Marasca, R., Rasi, S., Fangazio, M., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.060129 · Cited by 191
Villamor, N., Conde, L., Martínez-Trillos, A., Cazorla, M., Navarro, A., Beà, S., López, C., Colomer, D., Pinyol, M., Aymerich, M., et al. (2013) · Leukemia · doi:10.1038/leu.2012.357 · Cited by 190
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia
Pospisilova, S., Gonzalez, D., Malcikova, J., Trbusek, M., Rossi, D., Kater, A. P., Cymbalista, F., Eichhorst, B., Hallek, M., Döhner, H., et al. (2012) · Leukemia · doi:10.1038/leu.2012.25 · Cited by 189
Self-citationKennedy, B., Rawstron, A., Carter, C., Ryan, M., Speed, K., Lucas, G., & Hillmen, P. (2002) · Blood · doi:10.1182/blood.v99.6.2245 · Cited by 186
Molecular pathogenesis of chronic lymphocytic leukemia
Gaidano, G., Foà, R., & Dalla-Favera, R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64101 · Cited by 182
Schetelig, J., van Biezen, A., Brand, R., Caballero, D. M., Martino, R., Itälä, M., Garcia-Marco, J. A., Volin, L., Schmitz, N., Schwerdtfeger, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.2982 · Cited by 175
Rossi, D., Sozzi, E., Puma, A., Paoli, L. D., Rasi, S., Spina, V., Gozzetti, A., Tassi, M., Cencini, E., Raspadori, D., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07711.x · Cited by 172
Morrison, V. A. (2010) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2009.12.004 · Cited by 169
Zenz, T., Vollmer, D., Trbusek, M., Smardova, J., Benner, A., Soussi, T., Helfrich, H., Heuberger, M., Hoth, P., Fuge, M., et al. (2010) · Leukemia · doi:10.1038/leu.2010.208 · Cited by 169
Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia
Badoux, X. C., Keating, M. J., Wen, S., Lee, B.-N., Sivina, M., Reuben, J., Wierda, W. G., O'Brien, S. M., Faderl, S., Kornblau, S. M., et al. (2011) · Blood · doi:10.1182/blood-2011-03-339077 · Cited by 165
Pettitt, A. R., Jackson, R., Carruthers, S., Dodd, J., Dodd, S., Oates, M., Johnson, G. G., Schuh, A., Matutes, E., Dearden, C. E., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.9695 · Cited by 164
Fazi, C., Scarfò, L., Pecciarini, L., Cottini, F., Dagklis, A., Januś, A., Talarico, A., Scielzo, C., Sala, C. F., Toniolo, D., et al. (2011) · Blood · doi:10.1182/blood-2011-05-357251 · Cited by 164
Self-citationShanafelt, T. D., Kay, N. E., Rabe, K. G., Call, T. G., Zent, C. S., Maddocks, K. J., Jenkins, G. D., Jelinek, D. F., Morice, W. G., Boysen, J. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2704 · Cited by 159
Dagklis, A., Fazi, C., Sala, C. F., Cantarelli, V., Scielzo, C., Massacane, R., Toniolo, D., Caligaris‐Cappio, F., Σταματόπουλος, Κ., & Ghia, P. (2008) · Blood · doi:10.1182/blood-2008-09-176933 · Cited by 149
Self-citationMorphological and Immunophenotypic Features of Chronic Lymphocytic Leukemia
Matutes, E., & Polliack, A. (2000) · Reviews in Clinical and Experimental Hematology · doi:10.1046/j.1468-0734.2000.00002.x · Cited by 147
Alapat, D. V., Coviello‐Malle, J. M., Owens, R., Qu, P., Barlogie, B., Shaughnessy, J. D., & Lorsbach, R. B. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp59uorcyzevqo · Cited by 140
Bosch, F., Abrisqueta, P., Villamor, N., Terol, M. J., González-Barca, E. M., Ferra, C. M., González, M., Abella, E., Delgado, J., Carbonell, F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.0442 · Cited by 135
Goldin, L. R., Björkholm, M., Kristinsson, S. Y., Turesson, I., & Landgren, O. (2009) · Haematologica · doi:10.3324/haematol.2008.003632 · Cited by 130
Understanding and Managing Ultra High-Risk Chronic Lymphocytic Leukemia
Stilgenbauer, S., & Zenz, T. (2010) · Hematology · doi:10.1182/asheducation-2010.1.481 · Cited by 125
Slager, S. L., Benavente, Y., Blair, A., Vermeulen, R., Cerhan, J. R., Costantini, A. S., Monnereau, A., Nieters, A., Clavel, J., Call, T. G., et al. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu001 · Cited by 114
Castro, J. E., Sandoval-Sus, J. D., Bole, J., Rassenti, L. Z., & Kipps, T. J. (2008) · Leukemia · doi:10.1038/leu.2008.214 · Cited by 112
Best, G., Gardiner, A. C., Davis, Z. A., Tracy, I., Ibbotson, R. E., Majid, A., Dyer, M. J. S., & Oscier, D. G. (2008) · Leukemia · doi:10.1038/leu.2008.260 · Cited by 104
Parikh, S. A., Keating, M. J., O'Brien, S. M., Wang, X., Ferrajoli, A., Faderl, S. H., Burger, J. A., Koller, C. A., Estrov, Z. E., Badoux, X. C. A., et al. (2011) · Blood · doi:10.1182/blood-2011-01-329177 · Cited by 103
Elter, T., Gercheva, L., Pylylpenko, H., Robak, T., Jaksic, B. S., Rekhtman, G. B., Kyrcz‐Krzemień, S., Vatutin, M. T., Wu, J., Sirard, C. A., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70242-x · Cited by 99
Leprêtre, S., Aurran, T., Mahé, B., Cazin, B., Tournilhac, O., Maisonneuve, H., Casasnovas, O., Delmer, A. J., Leblond, V., Royer, B., et al. (2012) · Blood · doi:10.1182/blood-2011-07-365437 · Cited by 98
Schnaiter, A., Paschka, P., Rossi, M., Zenz, T., Bühler, A., Winkler, D. F. H., Cazzola, M., Döhner, K., Edelmann, J., Mertens, D., et al. (2013) · Blood · doi:10.1182/blood-2013-03-488197 · Cited by 88
Implications of new prognostic markers in chronic lymphocytic leukemia
Chiorazzi, N. (2012) · Hematology · doi:10.1182/asheducation.v2012.1.76.3806845 · Cited by 87
Rigolin, G. M., Cibien, F., Martinelli, S., Formigaro, L., Rizzotto, L., Tammiso, E., Saccenti, E., Bardi, A., Cavazzini, F., Ciccone, M., et al. (2012) · Blood · doi:10.1182/blood-2011-11-395269 · Cited by 87
Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemia
Strati, P., Keating, M. J., Wierda, W. G., Badoux, X. C. A., Calin, S., Reuben, J. M., O'Brien, S. M., Kornblau, S. M., Kantarjian, H. M., Gao, H., et al. (2013) · Blood · doi:10.1182/blood-2013-04-495341 · Cited by 86
Pettitt, A. R., Matutes, E., & Oscier, D. G. (2006) · Leukemia · doi:10.1038/sj.leu.2404265 · Cited by 84
Mansouri, L., Cahill, N., Gunnarsson, R., Smedby, K. E., Tjønnfjord, E. B., Hjalgrim, H., Juliusson, G., Geisler, C. H., & Rosenquist, R. (2012) · Leukemia · doi:10.1038/leu.2012.307 · Cited by 81
Sutton, L., Chevret, S., Tournilhac, O., Diviné, M., Leblond, V., Corront, B., Leprêtre, S., Eghbali, H., Neste, E. V. D., Michallet, M., et al. (2011) · Blood · doi:10.1182/blood-2010-11-317073 · Cited by 80
Vardi, A., Agathangelidis, A., Sutton, L., Ghia, P., Rosenquist, R., & Σταματόπουλος, Κ. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0630 · Cited by 76
Self-citationCorrection for Cimmino et al., miR-15 and miR-16 induce apoptosis by targeting BCL2
(2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510793103 · Cited by 72
How does lenalidomide target the chronic lymphocytic leukemia microenvironment?
Kater, A. P., Tonino, S. H., Egle, A., & Ramsay, A. G. (2014) · Blood · doi:10.1182/blood-2014-05-578286 · Cited by 68
López, C., Delgado, J., Costa, D., Conde, L., Ghita, G. L., Villamor, N., Navarro, A., Cazorla, M., Gómez, C., Arias, A., et al. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.21972 · Cited by 66
Isidoro, L., Pires, P., Rito, L., & Cordeiro, G. (2014) · BMJ Case Reports · doi:10.1136/bcr-2013-201781 · Cited by 55
Böttcher, S., Ritgen, M., & Dreger, P. (2011) · Blood Reviews · doi:10.1016/j.blre.2011.01.001 · Cited by 53
Management of chronic lymphocytic leukemia
Ghia, P., & Hallek, M. J. (2014) · Haematologica · doi:10.3324/haematol.2013.096107 · Cited by 53
Self-citationChronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment
Ponzoni, M., Doglioni, C., & Caligaris‐Cappio, F. (2011) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2011.02.014 · Cited by 52
Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL)
Winkler, D. F. H., Schneider, C., Kröber, A., Pasqualucci, L., Lichter, P., Döhner, H., & Stilgenbauer, S. (2005) · Leukemia · doi:10.1038/sj.leu.2403778 · Cited by 52
Prognostic Markers and Stratification of Chronic Lymphocytic Leukemia
Furman, R. R. (2010) · Hematology · doi:10.1182/asheducation-2010.1.77 · Cited by 50
Shanafelt, T. D., Kay, N. E., Rabe, K. G., Inwards, D. J., Zent, C. S., Leis, J. F., Schwager, S. M., Thompson, C. A., Bowen, D. A., Witzig, T. E., et al. (2011) · Cancer · doi:10.1002/cncr.26474 · Cited by 47
Microenvironmental Interactions in Chronic Lymphocytic Leukemia: The Master Role of CD49d
Bo, M. D., Tissino, E., Benedetti, D., Caldana, C., Bomben, R., Poeta, G. D., Gaïdano, G., Rossi, F. M., Zucchetto, A., & Gattei, V. (2014) · Seminars in Hematology · doi:10.1053/j.seminhematol.2014.05.002 · Cited by 44
Ibrutinib in relapsed chronic lymphocytic leukemia.
Byrd, J. C., O'Brien, S. M., & James, D. F. (2013) · PubMed · doi:10.1056/nejmc1309710 · Cited by 42
Evolving Understanding of the CLL Genome
Gruber, M., & Wu, C. J. (2014) · Seminars in Hematology · doi:10.1053/j.seminhematol.2014.05.004 · Cited by 41
Genetic Susceptibility to Chronic Lymphocytic Leukemia
Slager, S. L., Caporaso, N. E., de Sanjosé, S., & Goldin, L. R. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.09.007 · Cited by 32
Genetic variation and risk of chronic lymphocytic leukaemia
Crowther-Swanepoel, D., & Houlston, R. S. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.08.006 · Cited by 20
Next-Generation Sequencing in Chronic Lymphocytic Leukemia
Villamor, N., López‐Guillermo, A., López-Otín, C., & Campo, E. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.09.005 · Cited by 18
Ghia, P. (2012) · Hematology · doi:10.1182/asheducation.v2012.1.97.3798195 · Cited by 17
Self-citationTHE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Rossi, D., Fangazio, M., & Gaïdano, G. (2012) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2012.076 · Cited by 13
Cited by
Small Non-Coding RNAs in Leukemia
Balatti, V., & Croce, C. M. (2022) · Cancers · doi:10.3390/cancers14030509 · Cited by 14
“B cell chronic lymphocytic leukemia (CLL) is the most common human leukemia in the Western world [2].”
BackgroundInfluentialBiology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia
Wu, C.-H., Weng, T.-F., Li, J.-P., & Wu, K.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052527 · Cited by 13
Valsecchi, R., Coltella, N., Magliulo, D., Bongiovanni, L., Scarfò, L., Ghia, P., Ponzoni, M., & Bernardi, R. (2020) · Open Biology · doi:10.1098/rsob.190262 · Cited by 12
“CLL has a highly variable disease course, from an indolent disease that requires no immediate intervention to amore aggressive disorder that necessitates early treatment [2].”
BackgroundSelf-citation
Metadata
- Authors
- Scarfò, L., Ferreri, A. J. M., & Ghia, P.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 104
- Pages
- 169-182
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W2430283214
- Cited by
- 232
- References
- 107
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.